Ganglioside complex antibodies in an Indian cohort of Guillain‐Barré syndrome

Abstract

The GSC antibody-positive group had better outcome at hospital discharge in some of the disability scores. Pathophysiological pathways among patients without GSC antibodies may be different and this requires further evaluation.